nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—POLB—telencephalon—malignant glioma	0.0196	0.0491	CbGeAlD
Cytarabine—DCTD—retina—malignant glioma	0.0172	0.043	CbGeAlD
Cytarabine—DCTD—telencephalon—malignant glioma	0.0158	0.0396	CbGeAlD
Cytarabine—NT5E—embryo—malignant glioma	0.0151	0.0377	CbGeAlD
Cytarabine—POLE—embryo—malignant glioma	0.0147	0.0369	CbGeAlD
Cytarabine—POLB—midbrain—malignant glioma	0.0141	0.0353	CbGeAlD
Cytarabine—NT5E—retina—malignant glioma	0.0133	0.0333	CbGeAlD
Cytarabine—DCTD—medulla oblongata—malignant glioma	0.0124	0.0311	CbGeAlD
Cytarabine—NT5E—telencephalon—malignant glioma	0.0122	0.0306	CbGeAlD
Cytarabine—Adenosine monophosphate—PIM1—malignant glioma	0.0115	0.391	CrCbGaD
Cytarabine—DCTD—midbrain—malignant glioma	0.0114	0.0284	CbGeAlD
Cytarabine—POLA1—retina—malignant glioma	0.0112	0.0281	CbGeAlD
Cytarabine—POLB—central nervous system—malignant glioma	0.0112	0.0279	CbGeAlD
Cytarabine—DCTD—spinal cord—malignant glioma	0.0111	0.0277	CbGeAlD
Cytarabine—POLB—cerebellum—malignant glioma	0.0109	0.0273	CbGeAlD
Cytarabine—DCTD—central nervous system—malignant glioma	0.00899	0.0225	CbGeAlD
Cytarabine—POLD1—cerebellum—malignant glioma	0.00891	0.0223	CbGeAlD
Cytarabine—POLB—brain—malignant glioma	0.00886	0.0222	CbGeAlD
Cytarabine—DCTD—cerebellum—malignant glioma	0.00879	0.022	CbGeAlD
Cytarabine—NT5E—midbrain—malignant glioma	0.00879	0.022	CbGeAlD
Cytarabine—Glucosamine—IFNG—malignant glioma	0.00868	0.296	CrCbGaD
Cytarabine—NT5E—spinal cord—malignant glioma	0.00858	0.0215	CbGeAlD
Cytarabine—DCK—embryo—malignant glioma	0.00784	0.0196	CbGeAlD
Cytarabine—POLD1—brain—malignant glioma	0.00724	0.0181	CbGeAlD
Cytarabine—DCTD—brain—malignant glioma	0.00714	0.0179	CbGeAlD
Cytarabine—NT5E—central nervous system—malignant glioma	0.00696	0.0174	CbGeAlD
Cytarabine—DCK—retina—malignant glioma	0.00693	0.0173	CbGeAlD
Cytarabine—POLE—central nervous system—malignant glioma	0.00682	0.0171	CbGeAlD
Cytarabine—SLC29A1—telencephalon—malignant glioma	0.00667	0.0167	CbGeAlD
Cytarabine—POLE—cerebellum—malignant glioma	0.00666	0.0167	CbGeAlD
Cytarabine—DCK—telencephalon—malignant glioma	0.00637	0.0159	CbGeAlD
Cytarabine—ABCC10—telencephalon—malignant glioma	0.00607	0.0152	CbGeAlD
Cytarabine—POLA1—cerebellum—malignant glioma	0.00574	0.0144	CbGeAlD
Cytarabine—Glucosamine—MMP9—malignant glioma	0.00553	0.189	CrCbGaD
Cytarabine—NT5E—brain—malignant glioma	0.00552	0.0138	CbGeAlD
Cytarabine—SLC22A1—telencephalon—malignant glioma	0.00543	0.0136	CbGeAlD
Cytarabine—POLE—brain—malignant glioma	0.00541	0.0135	CbGeAlD
Cytarabine—DCK—medulla oblongata—malignant glioma	0.00501	0.0125	CbGeAlD
Cytarabine—ABCC10—medulla oblongata—malignant glioma	0.00477	0.0119	CbGeAlD
Cytarabine—POLA1—brain—malignant glioma	0.00466	0.0117	CbGeAlD
Cytarabine—DCK—midbrain—malignant glioma	0.00458	0.0114	CbGeAlD
Cytarabine—DCK—spinal cord—malignant glioma	0.00446	0.0112	CbGeAlD
Cytarabine—ABCC10—midbrain—malignant glioma	0.00436	0.0109	CbGeAlD
Cytarabine—ABCC10—spinal cord—malignant glioma	0.00425	0.0106	CbGeAlD
Cytarabine—SLC29A1—central nervous system—malignant glioma	0.00379	0.00949	CbGeAlD
Cytarabine—SLC29A1—cerebellum—malignant glioma	0.00371	0.00927	CbGeAlD
Cytarabine—Glucosamine—TNF—malignant glioma	0.00363	0.124	CrCbGaD
Cytarabine—DCK—central nervous system—malignant glioma	0.00362	0.00906	CbGeAlD
Cytarabine—DCK—cerebellum—malignant glioma	0.00354	0.00886	CbGeAlD
Cytarabine—ABCC10—cerebellum—malignant glioma	0.00337	0.00844	CbGeAlD
Cytarabine—SLC22A1—central nervous system—malignant glioma	0.00309	0.00773	CbGeAlD
Cytarabine—SLC29A1—brain—malignant glioma	0.00301	0.00753	CbGeAlD
Cytarabine—DCK—brain—malignant glioma	0.00288	0.00719	CbGeAlD
Cytarabine—ABCC10—brain—malignant glioma	0.00274	0.00685	CbGeAlD
Cytarabine—SLC22A1—brain—malignant glioma	0.00245	0.00614	CbGeAlD
Cytarabine—CYP3A4—central nervous system—malignant glioma	0.00141	0.00352	CbGeAlD
Cytarabine—POLD1—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000434	0.00076	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—MYC—malignant glioma	0.000434	0.00076	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TOP2A—malignant glioma	0.000432	0.000756	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00043	0.000754	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—H3F3A—malignant glioma	0.000427	0.000749	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000427	0.000747	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000424	0.000742	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000424	0.000742	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000419	0.000734	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000419	0.000733	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CG—malignant glioma	0.000417	0.000731	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—YWHAE—malignant glioma	0.000412	0.000721	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP2B6—malignant glioma	0.00041	0.000718	CbGpPWpGaD
Cytarabine—DCK—Metabolism—IDH2—malignant glioma	0.00041	0.000718	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—RTEL1—malignant glioma	0.000409	0.000716	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000408	0.000715	CbGpPWpGaD
Cytarabine—CDA—Metabolism—BCHE—malignant glioma	0.000404	0.000707	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PPARG—malignant glioma	0.000403	0.000706	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000402	0.000705	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000401	0.000702	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—malignant glioma	0.000399	0.000699	CbGpPWpGaD
Cytarabine—CDA—Metabolism—SLC5A5—malignant glioma	0.000399	0.000699	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000396	0.000694	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000395	0.000692	CbGpPWpGaD
Cytarabine—POLA1—S Phase—MYC—malignant glioma	0.000394	0.00069	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000391	0.000684	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.00039	0.000683	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—BIRC5—malignant glioma	0.000388	0.000679	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000387	0.000678	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP2B6—malignant glioma	0.000386	0.000675	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000382	0.000669	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TERT—malignant glioma	0.000376	0.000658	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—IDH1—malignant glioma	0.000375	0.000657	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—BIRC5—malignant glioma	0.000375	0.000656	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000372	0.000651	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—BCHE—malignant glioma	0.00037	0.000649	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000369	0.000645	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CD—malignant glioma	0.000367	0.000643	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000366	0.00064	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SPHK1—malignant glioma	0.000363	0.000636	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TERT—malignant glioma	0.000363	0.000636	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000361	0.000632	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP2C18—malignant glioma	0.000356	0.000623	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000355	0.000621	CbGpPWpGaD
Cytarabine—DCK—Metabolism—IDH1—malignant glioma	0.000353	0.000618	CbGpPWpGaD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000352	0.000616	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GSTP1—malignant glioma	0.000351	0.000615	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—SLC6A3—malignant glioma	0.000348	0.00061	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000346	0.000606	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—BCHE—malignant glioma	0.000345	0.000605	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000344	0.000602	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CAT—malignant glioma	0.000342	0.000599	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SPHK1—malignant glioma	0.000341	0.000598	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP2C18—malignant glioma	0.000334	0.000586	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000333	0.000584	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—SLC6A3—malignant glioma	0.000325	0.000569	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—NCOR1—malignant glioma	0.000323	0.000566	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GSTP1—malignant glioma	0.000321	0.000563	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000321	0.000563	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CB—malignant glioma	0.00032	0.00056	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—malignant glioma	0.000317	0.000555	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CAT—malignant glioma	0.000313	0.000548	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BRCA2—malignant glioma	0.000312	0.000547	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN2B—malignant glioma	0.000309	0.000542	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000301	0.000527	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000301	0.000526	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000299	0.000523	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000296	0.000519	CbGpPWpGaD
Cytarabine—CDA—Metabolism—NCOR1—malignant glioma	0.000295	0.000517	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GSTT1—malignant glioma	0.000288	0.000504	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000288	0.000504	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000278	0.000486	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000277	0.000485	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTEN—malignant glioma	0.000276	0.000484	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000271	0.000474	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GSTT1—malignant glioma	0.00027	0.000474	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS1—malignant glioma	0.00027	0.000472	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BIRC5—malignant glioma	0.000267	0.000468	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CAV1—malignant glioma	0.000263	0.000461	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000261	0.000456	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TERT—malignant glioma	0.000259	0.000453	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000258	0.000452	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN2A—malignant glioma	0.000257	0.00045	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000257	0.00045	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000256	0.000448	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000255	0.000446	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS1—malignant glioma	0.000253	0.000444	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—COX8A—malignant glioma	0.000252	0.000441	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—BCHE—malignant glioma	0.000251	0.000439	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MDM2—malignant glioma	0.000249	0.000437	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN2A—malignant glioma	0.000248	0.000435	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SLC5A5—malignant glioma	0.000247	0.000433	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000247	0.000432	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MDM2—malignant glioma	0.000241	0.000422	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CAV1—malignant glioma	0.000241	0.000422	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CG—malignant glioma	0.00024	0.00042	CbGpPWpGaD
Cytarabine—DCK—Metabolism—BCHE—malignant glioma	0.000236	0.000413	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000235	0.000412	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—COX8A—malignant glioma	0.000235	0.000411	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SLC5A5—malignant glioma	0.000233	0.000408	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PPARG—malignant glioma	0.000231	0.000405	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.00023	0.000403	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000227	0.000398	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000226	0.000395	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CG—malignant glioma	0.000219	0.000384	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ASMT—malignant glioma	0.000214	0.000375	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000214	0.000375	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PPARG—malignant glioma	0.000212	0.000371	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CD—malignant glioma	0.000211	0.000369	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000211	0.000369	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000207	0.000362	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000206	0.000361	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—BCAN—malignant glioma	0.000202	0.000353	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ASMT—malignant glioma	0.0002	0.00035	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.0002	0.00035	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GSTP1—malignant glioma	0.000199	0.000349	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000198	0.000347	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000198	0.000346	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000197	0.000345	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CA—malignant glioma	0.000195	0.000342	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MYC—malignant glioma	0.000195	0.000341	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CAT—malignant glioma	0.000194	0.00034	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CD—malignant glioma	0.000193	0.000338	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000193	0.000337	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000192	0.000336	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000192	0.000336	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—BRAF—malignant glioma	0.000189	0.000331	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MYC—malignant glioma	0.000188	0.00033	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—BCAN—malignant glioma	0.000188	0.000329	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GSTP1—malignant glioma	0.000187	0.000328	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000187	0.000328	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CB—malignant glioma	0.000184	0.000322	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000183	0.000321	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NCOR1—malignant glioma	0.000183	0.000321	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CAT—malignant glioma	0.000182	0.000319	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—malignant glioma	0.000182	0.000319	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN2A—malignant glioma	0.000177	0.00031	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—BRAF—malignant glioma	0.000176	0.000309	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000175	0.000306	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MYC—malignant glioma	0.000174	0.000305	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NCOR1—malignant glioma	0.000172	0.000302	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MDM2—malignant glioma	0.000172	0.000301	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MYC—malignant glioma	0.000168	0.000295	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CB—malignant glioma	0.000168	0.000294	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—malignant glioma	0.000167	0.000292	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—IDH2—malignant glioma	0.000162	0.000284	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—AKT1—malignant glioma	0.000159	0.000279	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTEN—malignant glioma	0.000159	0.000278	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—MDM2—malignant glioma	0.000158	0.000277	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—RAF1—malignant glioma	0.000158	0.000276	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP2B6—malignant glioma	0.000153	0.000267	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—IDH2—malignant glioma	0.000151	0.000265	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CAV1—malignant glioma	0.000149	0.000262	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000148	0.000259	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—MDM2—malignant glioma	0.000148	0.000259	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—RAF1—malignant glioma	0.000147	0.000258	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000146	0.000256	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTEN—malignant glioma	0.000145	0.000254	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000144	0.000252	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—malignant glioma	0.000143	0.000251	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP2B6—malignant glioma	0.000142	0.000249	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CAV1—malignant glioma	0.00014	0.000246	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—IDH1—malignant glioma	0.00014	0.000245	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—malignant glioma	0.000138	0.000242	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CG—malignant glioma	0.000136	0.000238	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SPHK1—malignant glioma	0.000135	0.000237	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MYC—malignant glioma	0.000134	0.000235	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP2C18—malignant glioma	0.000132	0.000232	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PPARG—malignant glioma	0.000131	0.00023	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—IDH1—malignant glioma	0.00013	0.000228	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CG—malignant glioma	0.000128	0.000224	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SPHK1—malignant glioma	0.000126	0.000221	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PPARG—malignant glioma	0.000123	0.000216	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP2C18—malignant glioma	0.000123	0.000216	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MYC—malignant glioma	0.00012	0.00021	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CD—malignant glioma	0.00012	0.000209	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CD—malignant glioma	0.000112	0.000197	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CA—malignant glioma	0.000112	0.000196	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTT1—malignant glioma	0.000107	0.000188	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CB—malignant glioma	0.000104	0.000183	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—malignant glioma	0.000103	0.000181	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CA—malignant glioma	0.000102	0.000179	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS1—malignant glioma	0.0001	0.000176	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTT1—malignant glioma	9.98e-05	0.000175	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—malignant glioma	9.85e-05	0.000172	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CB—malignant glioma	9.8e-05	0.000172	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—malignant glioma	9.71e-05	0.00017	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS1—malignant glioma	9.35e-05	0.000164	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—BCHE—malignant glioma	9.33e-05	0.000163	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC5A5—malignant glioma	9.22e-05	0.000161	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKT1—malignant glioma	9.15e-05	0.00016	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTEN—malignant glioma	9.01e-05	0.000158	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—BCHE—malignant glioma	8.7e-05	0.000152	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC5A5—malignant glioma	8.59e-05	0.00015	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	8.49e-05	0.000149	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—COX8A—malignant glioma	8.48e-05	0.000149	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTEN—malignant glioma	8.47e-05	0.000148	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKT1—malignant glioma	8.37e-05	0.000147	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—RAF1—malignant glioma	7.91e-05	0.000139	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTP1—malignant glioma	7.42e-05	0.00013	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CAT—malignant glioma	7.22e-05	0.000127	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ASMT—malignant glioma	7.21e-05	0.000126	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTP1—malignant glioma	6.92e-05	0.000121	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NCOR1—malignant glioma	6.82e-05	0.000119	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—BCAN—malignant glioma	6.78e-05	0.000119	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CAT—malignant glioma	6.73e-05	0.000118	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NCOR1—malignant glioma	6.36e-05	0.000111	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CA—malignant glioma	6.35e-05	0.000111	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CA—malignant glioma	5.97e-05	0.000105	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CAV1—malignant glioma	5.56e-05	9.74e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—IDH2—malignant glioma	5.47e-05	9.58e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKT1—malignant glioma	5.19e-05	9.09e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CAV1—malignant glioma	5.18e-05	9.08e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.14e-05	9e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CG—malignant glioma	5.07e-05	8.87e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PPARG—malignant glioma	4.89e-05	8.56e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKT1—malignant glioma	4.88e-05	8.55e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CG—malignant glioma	4.72e-05	8.27e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—IDH1—malignant glioma	4.7e-05	8.23e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PPARG—malignant glioma	4.56e-05	7.98e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SPHK1—malignant glioma	4.55e-05	7.97e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.46e-05	7.81e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CD—malignant glioma	4.45e-05	7.8e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CD—malignant glioma	4.15e-05	7.27e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CB—malignant glioma	3.88e-05	6.8e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—malignant glioma	3.85e-05	6.74e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CB—malignant glioma	3.62e-05	6.34e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTT1—malignant glioma	3.6e-05	6.31e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—malignant glioma	3.58e-05	6.28e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS1—malignant glioma	3.38e-05	5.92e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTEN—malignant glioma	3.35e-05	5.87e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—BCHE—malignant glioma	3.14e-05	5.5e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTEN—malignant glioma	3.13e-05	5.47e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.1e-05	5.43e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTP1—malignant glioma	2.5e-05	4.38e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CAT—malignant glioma	2.43e-05	4.26e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CA—malignant glioma	2.37e-05	4.14e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NCOR1—malignant glioma	2.3e-05	4.02e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CA—malignant glioma	2.21e-05	3.86e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKT1—malignant glioma	1.93e-05	3.39e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CAV1—malignant glioma	1.87e-05	3.28e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKT1—malignant glioma	1.8e-05	3.16e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.7e-05	2.99e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PPARG—malignant glioma	1.65e-05	2.88e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.5e-05	2.62e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.31e-05	2.29e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.29e-05	2.27e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTEN—malignant glioma	1.13e-05	1.98e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.96e-06	1.39e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKT1—malignant glioma	6.51e-06	1.14e-05	CbGpPWpGaD
